Thu, February 29, 2024
Wed, February 28, 2024
Tue, February 27, 2024

Gena Wang Maintained (BEAM) at Hold with Increased Target to $42 on, Feb 28th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-42-on-feb-28th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gena Wang of Barclays, Maintained "Beam Therapeutics Inc." (BEAM) at Hold with Increased Target from $26 to $42 on, Feb 28th, 2024.

Gena has made no other calls on BEAM in the last 4 months.



There are 3 other peers that have a rating on BEAM. Out of the 3 peers that are also analyzing BEAM, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Greg Harrison of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $35 on, Friday, December 15th, 2023
  • Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $30 on, Friday, December 8th, 2023


This is the rating of the analyst that currently disagrees with Gena


  • Eric Joseph of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $40 on, Monday, January 29th, 2024

Publication Contributing Sources